Sleep Disorders: January 2015

3.00 CME
0 MINS
$0 FEE
SAVE

Table of Contents

Insomnia

Susan Mackie, MD; and John W. Winkelman, MD, PhD

Obstructive Sleep Apnea: An Update for Mental Health Providers

Imran S. Khawaja, MD, FAASM; Ali Hashmi, MD; Ayesha Ebrahim, MD; Connie Ullevig, RN; Asim Shah, MD; and Thomas D. Hurwitz, MD

Hypersomnolence Disorders in DSM-5: A Review for Clinicians

Elliott Kyung Lee, MD, FRCPC; and Louis Kazaglis, MD

Parasomnias: An Update

Michael J. Howell, MD; Imran S. Khawaja, MD; and Carlos H. Schenck, MD

An Overview of Restless Leg Syndrome for the Mental Health Professional

Shehzad Niazi, MD, FRCPC; R. Robert Auger, MD; and Thomas D. Hurwitz, MD

Sponsorship Statement: This CME activity is jointly sponsored by Keck School of Medicine of USC and Psychiatric Annals.

Support Statement: There is no commercial support for this activity.

Learning Objectives:
1. Recognize insomnia and treatment options in psychiatric patients.
2. Analyze obstructive sleep apnea, its diagnosis, management, and treatmentoptions.
3. Describe the updated classification of hypersomnolence disorders in DSM-5, including neuroanatomical basis, symptoms, and treatment.
4. Recognize that parasomnias are common, disabling, often mistreated, and reversible.
5. Define the diagnosis, impact, and treatment of restless leg syndrome/Willis-Ekbom disease.

Faculty names and affiliations:  See authors above

Guest Editors: Imran S. Khawaja, MD; and Thomas D. Hurwitz, MD

Reviewer names:  Jan Fawcett, MD, Editor, Psychiatric Annals; Andrew A. Nierenberg, MD, CME Coordinator, Psychiatric Annals

Disclosure statement:  In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears at the beginning of each CME-accredited article in this issue and also on this page.

Faculty members report the following financial relationships:  

Jan Fawcett, MD, has no relevant financial relationships to disclose.

Andrew A. Nierenberg, MD, has disclosed the following relevant financial relationships: Appliance Computing Inc. (Mindsite); Astra Zeneca; Brain Cells, Inc.; Brandeis University; Bristol Myers Squibb; Clintara, Dianippon Sumitomo/Sepracor; Eli Lilly and Company; EpiQ, Forest; Johnson and Johnson; Labopharm; Merck; Methylation Science; Novartis; PamLabs; PGx Health; Shire; Schering-Plough; Sunovion; Takeda/Lundbeck Pharmaceuticals; Targacept; Teva: Consultant. APSARD; Belvoir Publishing; Boston Center for the Arts; University of Texas Southwestern Dallas; Hillside Hospital; American Drug Utilization Review; American Society for Clinical Psychopharmacology; Bayamon Region Psychiatric Society; Baystate Medical Center; Canadian Psychiatric Association; Columbia University; Douglas Hospital/McGill University; IMEDEX; International Society for Bipolar Disorders; Israel Society for Biological Psychiatry; John Hopkins University; MJ Consulting; Massachusetts Association of College Counselors; Medscape; MBL Publishing; Physicians Postgraduate Press; Ryan Licht Sang Foundation; Slack Publishing; SUNY Buffalo; University of Florida; University of Miami; University of Wisconsin; University of Pisa; SciMed: Honoraria / travel expenses. Appliance Computing, Inc.; Brain Cells, Inc.: Stock options. AHRQ; Cephalon; Forest; Mylan; NIMH; PamLabs; Pfizer Pharmaceuticals; Takeda; Elan; Shire: Grant / research support.

Authors report the following financial relationships: Susan Mackie has no relevant financial relationships to disclose. John W. Winkelman discloses consulting fees from UCB Pharma, Insys, FlexPharma, and Merck & Co.; contracted research for UCB Pharma and Purdue; and expert testimony for Cantor Colburn. Imran S. Khawaja has no relevant financial relationships to disclose. Ali Hashmi has no relevant financial relationships to disclose. Ayesha Ebrahim has no relevant financial relationships to disclose. Connie Ullevig has no relevant financial relationships to disclose. Asim Shah discloses fees for noncontinuing medical education services from Otsuka; and contracted research for Roche Bristol-Myers Squibb Synchroneuron for Research. Thomas D. Hurwitz has no relevant financial relationships to disclose. Elliott Kyung Lee discloses a salary from Sleep Strategies. Louis Kazaglis has no relevant financial relationships to disclose. Michael J. Howell has received consulting fees from Inspire Medical and has done contracted research for General Electric. Carlos H. Schenck has no relevant financial relationships to disclose. Shehzad Niazi has no relevant financial relationships to disclose. R. Robert Auger has no relevant financial relationships to disclose.

The staff of Keck School of Medicine of USC and Psychiatric Annals have disclosed no relevant financial relationships.  

Signed disclosures are on file at Keck School of Medicine of USC.

Accreditation statement(s):  This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Keck School of Medicine of USC and SLACK Incorporated. The Keck School of Medicine of USC is accredited by the ACCME to provide continuing medical education for physicians.

Credit designation: The Keck School of Medicine of USC designates this enduring material for a maximum of 3 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Release date:  January 1, 2015.

Expiration Date:  January 31, 2018.

How to participate:  To participate in this CME activity, you must read the learning objectives, answer the pretest questions, read the articles, complete the CME posttest, and complete the evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 70% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Keck School of Medicine of USC will issue an AMA PRA Category 1 Credit(s)™ certificate.

Target audience:  This CME activity is primarily targeted to patient-caring psychiatrists, physicians specializing in psychiatry and others allied to the field. There are no specific background requirements for participants taking this activity. Learning objectives and author disclosures are found at the beginning of each CME article.

Unlabeled and investigational usage statement:  The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage.

Copyright statement:  Copyright © 2015 by SLACK Incorporated. All rights reserved. No part of this publication may be reproduced without prior written consent of the publisher.